Pharmacogenomics and asthma treatment: acceptability to children, families and healthcare professionals

Parry, Christopher Mark ORCID: 0000-0002-0256-1325, Seddon, Gabrielle, Rogers, Naomi, Sinha, Ian P, Bracken, Louise, King, Charlotte ORCID: 0000-0002-7887-3640, Peak, Matthew and Hawcutt, Daniel B ORCID: 0000-0002-8120-6507 (2022) Pharmacogenomics and asthma treatment: acceptability to children, families and healthcare professionals. ARCHIVES OF DISEASE IN CHILDHOOD, 107 (4). pp. 394-399.

Text CHANGE - Main Document_revised_marked copy DH.docx - Author Accepted Manuscript Available under License Creative Commons Attribution Non-commercial. Download (115kB)

Abstract

<h4>Background</h4>Evidence supporting personalised treatment for asthma based on an individual's genetics is mounting. The views of children and young people (CYP), parents and healthcare professionals (HCPs) about this evolution of clinical care are not known.<h4>Methods</h4>A pilot prospective questionnaire-based study was undertaken of CYP with asthma, their parents and HCPs at a secondary/tertiary children's hospital in the UK.<h4>Results</h4>Fifty-nine questionnaires were distributed and 50 returned (response rate 84.7%), comprising 26 CYP (10 were 5-11 years, 11 were 12-15 years and 5 were 16-18 years old), 13 parents and 11 HCPs. For all types of data, personal information was ranked as the 'most important' (n=19, 47.5%) and 'most private' (n=16, 40%), but with considerable variation across groups. Within health data, allergies were rated as 'most important' (n=12, 30.8%), and mental health records the 'most private' (n=21, 53.8%), again with variation across groups. A 'personalised genetic asthma plan' was acceptable to the majority overall (n=40, 80.0%). With regard to sharing CYP's genetic data, 23 (46%) of participants were happy for unconditional sharing between HCPs, and 23 (46%) agreed to sharing solely in relation to the CYP's asthma management. Forty-two (84.0%) of participants felt CYP should be informed about genetic data being shared, and the majority felt this should commence by 12 years of age.<h4>Conclusion</h4>The use of genetic information to guide management of asthma in CYP is largely acceptable to CYP, parents/guardians and HCPs. However, there are key differences between the opinions of CYP, parents and HCPs.

Item Type:	Article
Uncontrolled Keywords:	Humans, Asthma, Prospective Studies, Parents, Pharmacogenetics, Adolescent, Child, Delivery of Health Care
Divisions:	Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Clinical Directorate Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User:	Symplectic Admin
Date Deposited:	01 Feb 2022 09:53
Last Modified:	18 Jan 2023 21:14
DOI:	10.1136/archdischild-2021-322396
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3147939